StrongBox Wealth LLC Has $1.75 Million Stake in Kenvue Inc. (NYSE:KVUE)

StrongBox Wealth LLC lifted its stake in Kenvue Inc. (NYSE:KVUE) by 8.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 82,057 shares of the company’s stock after buying an additional 6,085 shares during the period. StrongBox Wealth LLC’s holdings in Kenvue were worth $1,752,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Huntington National Bank boosted its stake in shares of Kenvue by 26.5% in the third quarter. Huntington National Bank now owns 4,161 shares of the company’s stock valued at $96,000 after buying an additional 871 shares during the period. ING Groep NV boosted its stake in shares of Kenvue by 23.6% in the third quarter. ING Groep NV now owns 3,576,616 shares of the company’s stock valued at $82,727,000 after buying an additional 681,954 shares during the period. Saturna Capital Corp boosted its stake in shares of Kenvue by 29.9% in the third quarter. Saturna Capital Corp now owns 1,334,860 shares of the company’s stock valued at $30,875,000 after buying an additional 307,039 shares during the period. Everence Capital Management Inc. lifted its stake in Kenvue by 122.1% during the fourth quarter. Everence Capital Management Inc. now owns 45,380 shares of the company’s stock worth $969,000 after purchasing an additional 24,950 shares during the last quarter. Finally, Tyler Stone Wealth Management lifted its stake in Kenvue by 134.4% during the third quarter. Tyler Stone Wealth Management now owns 49,050 shares of the company’s stock worth $1,135,000 after purchasing an additional 28,125 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

KVUE has been the subject of several recent analyst reports. Barclays upgraded Kenvue to a “hold” rating in a research note on Thursday, December 12th. Citigroup cut their target price on Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a research note on Wednesday. Royal Bank of Canada upgraded Kenvue from a “hold” rating to a “moderate buy” rating in a research note on Monday, December 9th. Jefferies Financial Group initiated coverage on Kenvue in a research note on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft cut Kenvue from a “buy” rating to a “hold” rating and cut their target price for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. One analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $23.18.

Kenvue Stock Down 1.0 %

Shares of NYSE:KVUE opened at $20.83 on Thursday. The company has a fifty day moving average of $22.50 and a 200-day moving average of $21.64. The company has a market capitalization of $39.94 billion, a PE ratio of 37.87, a price-to-earnings-growth ratio of 1.99 and a beta of 1.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $24.46.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. Kenvue’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.31 earnings per share. On average, equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.